NO950757L - Antitussiv - Google Patents

Antitussiv

Info

Publication number
NO950757L
NO950757L NO950757A NO950757A NO950757L NO 950757 L NO950757 L NO 950757L NO 950757 A NO950757 A NO 950757A NO 950757 A NO950757 A NO 950757A NO 950757 L NO950757 L NO 950757L
Authority
NO
Norway
Prior art keywords
antitussives
salts
derivatives
useful
compound
Prior art date
Application number
NO950757A
Other languages
English (en)
Norwegian (no)
Other versions
NO950757D0 (no
Inventor
Hiroshi Nagase
Koji Kawai
Takashi Endoh
Shinya Ueno
Yuji Negishi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO950757D0 publication Critical patent/NO950757D0/no
Publication of NO950757L publication Critical patent/NO950757L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
NO950757A 1993-06-30 1995-02-27 Antitussiv NO950757L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16162693 1993-06-30
PCT/JP1994/001047 WO1995001178A1 (fr) 1993-06-30 1994-06-28 Antitussif

Publications (2)

Publication Number Publication Date
NO950757D0 NO950757D0 (no) 1995-02-27
NO950757L true NO950757L (no) 1995-04-27

Family

ID=15738765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950757A NO950757L (no) 1993-06-30 1995-02-27 Antitussiv

Country Status (11)

Country Link
US (1) US5739145A (de)
EP (1) EP0657163B1 (de)
KR (1) KR950702833A (de)
CN (1) CN1111900A (de)
AU (1) AU683664B2 (de)
CA (1) CA2143318A1 (de)
DE (1) DE69413933T2 (de)
FI (1) FI950908A (de)
NO (1) NO950757L (de)
TW (1) TW329386B (de)
WO (1) WO1995001178A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323212B1 (en) 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications
WO1995003307A1 (fr) * 1993-07-19 1995-02-02 Toray Industries, Inc. Agent de protection de cellules cerebrales
JP3843456B2 (ja) * 1993-07-23 2006-11-08 東レ株式会社 モルヒナン誘導体および医薬用途
EP0829481A1 (de) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan-Hydroxamsäure-Derivate
US6440987B1 (en) 1996-11-25 2002-08-27 Toray Industries, Inc. Antipruritic
ATE291429T1 (de) 1996-11-25 2005-04-15 Toray Industries Mittel gegen juckreiz
US6403602B1 (en) * 1997-02-20 2002-06-11 The University Of Kentucky Research Foundation Morphine-6-sulfate analogues and their use for the treatment of pain
CA2383146C (en) * 1999-08-24 2010-11-16 Hiroshi Nagase Therapeutic agent for neuropathic pain and neuropathic pain animal model
WO2002080918A1 (fr) * 2001-04-02 2002-10-17 Toray Industries, Inc. Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire
ES2568475T3 (es) 2005-04-06 2016-04-29 Toray Industries, Inc. Cristales de derivado de morfinano y procedimiento para producir los mismos
CA2685126C (en) 2007-04-24 2015-04-14 Toray Industries, Inc. Therapeutic or prophylactic agent for dyskinesia
EP2168580B1 (de) * 2007-06-22 2015-12-02 Toray Industries, Inc. Heilmittel oder prophylaktikum für schizophrenie
AU2009214500B2 (en) 2008-02-14 2014-10-23 Alkermes, Inc. Selective opioid compounds
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
JP2012518651A (ja) * 2009-02-23 2012-08-16 マリンクロッド インコーポレイテッド (+)−モルフィナニウムn−オキシドおよびそれらの生成方法
EP2398807A1 (de) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-6-hydroxymorphinan- oder (+)-6-aminomorphinanderivate
CN102325776A (zh) * 2009-02-23 2012-01-18 马林克罗特公司 (+)-吗啡喃*季盐及其制备方法
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
BR112012018765B1 (pt) 2010-01-29 2019-09-03 Toray Industries uso de um derivado de morfinano como agente profilático ou terapêutico em doenças do trato biliar
CN103261203B (zh) 2010-10-19 2017-06-20 纪念斯隆-凯特琳癌症中心 用于治疗疼痛的4,5a‑环氧基吗啡喃的6‑酰氨基衍生物
CN103327977B (zh) 2011-01-31 2016-05-04 东丽株式会社 恶液质的治疗或预防剂
RU2014112493A (ru) 2011-09-08 2015-10-20 МАЛЛИНКРОДТ Эл-Эл-Си Получения алкалоидов без выделения промежуточных продуктов
CA2983314A1 (en) 2015-04-30 2016-11-03 Memorial Sloan-Kettering Cancer Center Mitragynine analogs and uses thereof
CN105461727A (zh) * 2015-12-01 2016-04-06 吕涛 一种纳呋拉啡的精制方法
CN106866688B (zh) * 2015-12-10 2019-05-03 山东诚创医药技术开发有限公司 一种纳呋拉啡的精制方法
CN115181109A (zh) * 2021-04-02 2022-10-14 南京正大天晴制药有限公司 吗啡喃衍生物的晶体及其制备方法
CN114736210A (zh) * 2022-03-29 2022-07-12 伊诺药物研究(南京)有限公司 吗啡喃衍生物的一种晶型的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB843908A (en) * 1957-12-20 1960-08-10 Hoffmann La Roche Novel morphinan derivatives and the manufacture thereof
FR1503524A (fr) * 1964-10-17 1967-12-01 Tanabe Seiyaku Co Morphine à noyaux b/c condensés en configuration trans, et son procédé de préparation
US3865943A (en) * 1971-02-19 1975-02-11 Boehringer Sohn Ingelheim Pharmaceutical compositions containing an n-(furyl-methyl)-3-oxy-morphinan and method of use
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
US3880863A (en) * 1973-08-31 1975-04-29 Warner Lambert Co 17-Aralkyl-6 beta-azido-4,5 alpha-epox-ymorphinan-3-01{hu s
US4521601A (en) * 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4401672A (en) * 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
US4613668A (en) * 1983-12-22 1986-09-23 The United States Of America As Represented By The Department Of Health And Human Services Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US4912114A (en) * 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
JPH03163030A (ja) * 1989-08-28 1991-07-15 Arizona Technol Dev Corp アヘン剤活性を選択的に強化し、アヘン剤耐性と依存性を軽減するための組成物と方法
US6323212B1 (en) * 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications

Also Published As

Publication number Publication date
EP0657163A4 (de) 1995-12-13
FI950908A0 (fi) 1995-02-28
AU683664B2 (en) 1997-11-20
US5739145A (en) 1998-04-14
DE69413933D1 (de) 1998-11-19
WO1995001178A1 (fr) 1995-01-12
DE69413933T2 (de) 1999-04-08
CA2143318A1 (en) 1995-01-12
FI950908A (fi) 1995-04-28
KR950702833A (ko) 1995-08-23
TW329386B (en) 1998-04-11
AU6984494A (en) 1995-01-24
EP0657163B1 (de) 1998-10-14
EP0657163A1 (de) 1995-06-14
NO950757D0 (no) 1995-02-27
CN1111900A (zh) 1995-11-15

Similar Documents

Publication Publication Date Title
NO950757L (no) Antitussiv
DK0696280T3 (da) Substituerede pyrrolidin-3-yl-alkyl-piperidiner anvendelige som tachykinin-antagonister
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
YU59098A (sh) Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži
DK0726893T3 (da) Hidtil ukendte 4-piperidinyl-substituerede lactamer som neurokinon 2-receptor-antagonister til behandling af astma
AU1442297A (en) Piperidone tachykinin antagonists
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
NO20044810L (no) Farmasoytisk formulering med oyeblikkelig frigjoring
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
IT1283110B1 (it) Composti a scheletro colchicinico,loro uso come farmaci e composizioni che li contengono
ES2180751T3 (es) Inhibidor de metastasis de cancer.
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
KR960000225A (ko) 기관지천식 치료제
MXPA04004371A (es) Agente antipruritico.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
ATE287895T1 (de) Substituierte tetrahydropyranderivate sowie verfahren zu deren herstellung
UY26971A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
EP0700395A1 (de) INDOLDERIVATE ALS STEROID 5-g-REDUKTASE-INHIBITOREN
SE9304065D0 (sv) New compound
NO305123B1 (no) Fluorfenoksybutyl-piperidinyl-metyl-aminobenzotiazoler som antiarytmiske midler av klasse III